Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medtronic plc Proxy Solicitation & Information Statement 2020

Oct 13, 2020

29841_rns_2020-10-13_eaf52deb-a089-4c1a-a59d-6963a406248c.zip

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

DEFA14A 1 d941945ddefa14a.htm DEFA14A DEFA14A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No. )

☒ Filed by the Registrant ☐ Filed by a Party other than the Registrant

Check the appropriate box:

Preliminary Proxy Statement
CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials
Soliciting Material Pursuant to §240.14a-12

MEDTRONIC PLC

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

No fee required.
Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
(1) Title of each class of securities to which transaction applies:
(2) Aggregate number of securities to which transaction applies:
(3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
(4) Proposed maximum aggregate value of transaction:
(5) Total fee paid:
Fee paid previously with preliminary materials.
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the
previous filing by registration statement number, or the Form or Schedule and the date of its filing.
(1) Amount Previously Paid:
(2) Form, Schedule or Registration Statement No.:
(3) Filing Party:
(4) Date Filed:

* Exercise Your Right to Vote ***

Important Notice Regarding the Availability of Proxy Materials for the

2020 Annual General Meeting to Be Held Virtually on December 11, 2020.

Meeting Information Meeting Type: Annual General Meeting For holders as of: October 15, 2020
Date: December 11, 2020 Time: 9:00 AM U.S. Central
Time
(3:00 PM Irish Time)
Location: Meeting live via the Internet-please visit
www.virtualshareholdermeeting.com/MDT2020.
MEDTRONIC PLC ATTN: MARCY CAMAROTTO 710 MEDTRONIC PARKWAY MS LC300 MINNEAPOLIS, MN 55432-5604 You are receiving this communication because you hold shares in
the company named above. This is not a ballot. You cannot use
this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com , or scan the QR
Barcode on the reverse side, or easily request a paper copy (see reverse side). We encourage you to access and review all of the important information contained in the proxy materials before voting.
See the reverse side
of this notice to obtain proxy materials and voting instructions.
Before You Vote
How to Access the Proxy Materials
Proxy Materials Available to VIEW or RECEIVE:
PROXY
STATEMENT ANNUAL REPORT
How to View Online:
Have the information that is printed in the box marked by the arrow (located on the following page) and visit: www.proxyvote.com, or scan the QR Barcode below.
How to Request and Receive a PAPER or E-MAIL Copy:
If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the
following methods to make your request:
1) BY INTERNET : www.proxyvote.com
2) BY TELEPHONE : 1-800-579-1639
3) BY E-MAIL* : [email protected]
*  If requesting materials
by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow (located on the following page) in the subject line.
Requests, instructions and other inquiries sent
to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before November 29, 2020 to facilitate
timely delivery.

How To Vote Please Choose One of the Following Voting Methods

Vote By Mail: You can vote by mail by requesting a paper copy of the
materials, which will include a proxy card.
Vote By Phone: To vote by telephone, go
to www.proxyvote.com to view the proxy materials and obtain the toll free number to call. Have the information that is printed in the box marked by the arrow (located on the following page) available and follow the instructions.

Voting Items

| To elect, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2021
Annual General Meeting of the Company. | |
| --- | --- |
| Nominees: | |
| 1a. | Richard H. Anderson |
| 1b. | Craig Arnold |
| 1c. | Scott C. Donnelly |
| 1d. | Andrea J. Goldsmith, Ph.D. |
| 1e. | Randall J. Hogan, III |
| 1f. | Michael O. Leavitt |
| 1g. | James T. Lenehan |
| 1h. | Kevin E. Lofton |
| 1i. | Geoffrey S. Martha |
| 1j. | Elizabeth G. Nabel, M.D. |
| 1k. | Denise M. O’Leary |
| 1l. | Kendall J. Powell |

| 2. | To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditor
for fiscal year 2021 and to authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor’s remuneration. |
| --- | --- |
| 3. | To approve, in a non-binding advisory vote, named executive officer compensation (a “Say-on-Pay”
vote). |
| 4. | To renew the Board’s authority to issue shares. |
| 5. | To renew the Board’s authority to opt out of pre-emption rights. |
| 6. | Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary
shares. |
| 7. | Transacting any other business that may properly come before the
meeting. |